\n\t
The increasing burden of lifestyle diseases and rising adoption of a sedentary lifestyle are responsible for the increasing incidence of Erectile Dysfunction (ED) worldwide. According to World Health Organization (WHO) report, around 15% of the male population were reported to be affected by erectile dysfunction every year which is projected to reach 320 million by 2025.<\/p>\n<\/div>\n\t<\/div>\n<\/div>\n
\n\t
\n\t\t
\n\t
\n- Revenue in the Incontinence segment amounts to US$4.06bn in 2023. The market is expected to grow annually by 75% (CAGR 2023-2027).<\/li>\n
- The global incontinence care products market size was valued at USD 14.30 billion in 2018 and is projected to reach USD 24.35 billion by 2026, exhibiting a CAGR of 6.9% during the forecast period.<\/li>\n
- Erectile Dysfunction Market size was valued at\u00a0USD 2.3 billion in 2021and is poised to grow from USD 2.49 billion in 2022 to USD 4.73 billion by 2030, growing at a CAGR of 8.5% in the forecast period (2023-2030).<\/li>\n
- The Female Sexual Dysfunction Treatment Market is expected to grow by $7760.77 mn during 2023-2027, accelerating at a CAGR of 34.28% during the forecast period<\/li>\n
- The global erectile dysfunction drugs market was valued at USD 2.30\u00a0billion in 2021 and is expected to expand at a compounded annual growth rate (CAGR) of 8.5% from 2022 to 2030.<\/li>\n<\/ul>\n<\/div>\n\t<\/div>\n<\/div>\n\t<\/div>\n<\/div>\n\t\t\t
\n\t
\n\t
\n\t
\n\t\t
\n\t
\n\t\t\t\t
\n\t\t\t\t\t<\/div>\n\t<\/div>\n\t<\/div>\n<\/div>\n\t<\/div>\n<\/div>\n\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n
\n\t
\n\t\t\t\t\t\t
\n\t\t\n
\n\t\t\t
\n\t
\n\t
\n\t
\n\t\t
\n\t\tINCONTINENCE AND SEXUAL DYSFUNCTION<\/span>\n\t<\/h2>\n\t<\/div>\n<\/div>\n\t<\/div>\n<\/div>\n\t<\/div>\n\n